CITALOPRAM Drug Patent Profile
✉ Email this page to a colleague
When do Citalopram patents expire, and what generic alternatives are available?
Citalopram is a drug marketed by Almatica, Aurobindo Pharma Ltd, Pharmobedient, Aurobindo Pharma, Chartwell Molecular, Hetero Labs Ltd Iii, Hikma, Pharm Assoc, Biovail Labs Intl, Amneal Pharms Ny, Apotex, Aurobindo, Chartwell Rx, Cosette, Dr Reddys Labs Ltd, Epic Pharma, Epic Pharma Llc, Fosun Pharma, Glenmark Pharms Ltd, Heritage Pharma, Invagen Pharms, Jubilant Generics, Mylan, Natco Pharma Ltd, Roxane, Sun Pharm Inds Inc, Sun Pharm Industries, Taro, and Torrent Pharms. and is included in thirty-five NDAs.
The generic ingredient in CITALOPRAM is citalopram hydrobromide. There are fifty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the citalopram hydrobromide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Citalopram
A generic version of CITALOPRAM was approved as citalopram hydrobromide by AUROBINDO on October 28th, 2004.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CITALOPRAM?
- What are the global sales for CITALOPRAM?
- What is Average Wholesale Price for CITALOPRAM?
Summary for CITALOPRAM
| US Patents: | 0 |
| Applicants: | 29 |
| NDAs: | 35 |
| Drug Prices: | Drug price information for CITALOPRAM |
| Drug Sales Revenues: | Drug sales revenues for CITALOPRAM |
| What excipients (inactive ingredients) are in CITALOPRAM? | CITALOPRAM excipients list |
| DailyMed Link: | CITALOPRAM at DailyMed |
US Patents and Regulatory Information for CITALOPRAM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077037-002 | Nov 5, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fosun Pharma | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077035-001 | Oct 28, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys Labs Ltd | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077038-001 | Oct 28, 2004 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Taro | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077278-002 | Mar 22, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
